Irras

About:

Sweden-based commercial-stage medical technology company

Website: http://irras.com/

Twitter/X: irrasab

Top Investors: Ixora Ventures, Bacara Holdings, IR Holding Bidco, The Vandel Group

Description:

IRRAS AB is a medical technology company that is developing breakthrough devices to meet the challenges of fluid control and management for a broad range of brain pathologies, CNS therapeutic applications and procedures. IRRAS has successfully developed first-in-class instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow™. Our transformative technology provides intelligent, dynamic control of brain fluids, for irrigation and aspiration, precise infusion of fluids and intracranial pressure monitoring all in one unit, without additional equipment or more invasive procedures.

Total Funding Amount:

$21M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

San Diego, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)irras.com

Founders:

Christos Panotopoulos

Number of Employees:

51-100

Last Funding Date:

2023-04-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai